APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Heart Lung Machines

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Selected research

Market Outlook & Growth Opportunities

Global Artificial Heart Lung Machines Market Outlook and Growth Opportunities 2026

1 January 2026192 pages

Choose your research edition.

Industry ResearchArtificial Heart Lung Machines Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Heart Lung Machines Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Artificial Heart Lung Machines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Heart Lung Machines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Heart Lung Machines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.

This report provides an overview of the global Artificial Heart Lung Machines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Artificial Heart Lung Machines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Heart Lung Machines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artificial Heart Lung Machines market size, projected growth trends, production technologies, key applications, and end-use industries.

Artificial Heart Lung Machines Segment by Company

LivaNova (Sorin)

Getinge (Maquet)

Medtronic

Terumo CV Group

Braile Biomedica

Tianjin Medical

Artificial Heart Lung Machines Segment by Type

Single Roller Pump HLM

Double Roller Pump HLM

Artificial Heart Lung Machines Segment by Application

Cardiac Surgery

Lung Transplant Operation

Acute Respiratory Failure Treatment

Others

Artificial Heart Lung Machines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Heart Lung Machines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Artificial Heart Lung Machines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Heart Lung Machines significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Heart Lung Machines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Heart Lung Machines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Heart Lung Machines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Heart Lung Machines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artificial Heart Lung Machines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Heart Lung Machines industry.

Chapter 3: Detailed analysis of Artificial Heart Lung Machines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Artificial Heart Lung Machines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Artificial Heart Lung Machines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Heart Lung Machines Industry Trends Table 2. Artificial Heart Lung Machines Industry Drivers Table 3. Artificial Heart Lung Machines Industry Opportunities and Challenges Table 4. Artificial Heart Lung Machines Industry Restraints Table 5. Global Artificial Heart Lung Machines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Heart Lung Machines Revenue Share by Company (2021-2026) Table 7. Global Artificial Heart Lung Machines Sales Volume by Company (Units) & (2021-2026) Table 8. Global Artificial Heart Lung Machines Sales Volume Share by Company (2021-2026) Table 9. Global Artificial Heart Lung Machines Average Price (K USD/Unit) of Company (2021-2026) Table 10. Global Artificial Heart Lung Machines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Artificial Heart Lung Machines Key Company Manufacturing Base & Headquarters Table 12. Global Artificial Heart Lung Machines Company, Product Type & Application Table 13. Global Artificial Heart Lung Machines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Artificial Heart Lung Machines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Roller Pump HLM Table 18. Significant Companies of Double Roller Pump HLM Table 19. Global Artificial Heart Lung Machines Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Artificial Heart Lung Machines Sales Volume by Type (2021-2026) & (Units) Table 21. Global Artificial Heart Lung Machines Sales Volume by Type (2027-2032) & (Units) Table 22. Global Artificial Heart Lung Machines Sales Volume Share by Type (2021-2026) Table 23. Global Artificial Heart Lung Machines Sales Volume Share by Type (2027-2032) Table 24. Global Artificial Heart Lung Machines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Artificial Heart Lung Machines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Artificial Heart Lung Machines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Artificial Heart Lung Machines Sales Value Share by Type (2021-2026) Table 28. Global Artificial Heart Lung Machines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cardiac Surgery Table 30. Significant Companies of Lung Transplant Operation Table 31. Significant Companies of Acute Respiratory Failure Treatment Table 32. Significant Companies of Others Table 33. Global Artificial Heart Lung Machines Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Artificial Heart Lung Machines Sales Volume by Application (2021-2026) & (Units) Table 35. Global Artificial Heart Lung Machines Sales Volume by Application (2027-2032) & (Units) Table 36. Global Artificial Heart Lung Machines Sales Volume Share by Application (2021-2026) Table 37. Global Artificial Heart Lung Machines Sales Volume Share by Application (2027-2032) Table 38. Global Artificial Heart Lung Machines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Artificial Heart Lung Machines Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Artificial Heart Lung Machines Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Artificial Heart Lung Machines Sales Value Share by Application (2021-2026) Table 42. Global Artificial Heart Lung Machines Sales Value Share by Application (2027-2032) Table 43. Global Artificial Heart Lung Machines Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Artificial Heart Lung Machines Sales by Region (2021-2026) & (Units) Table 45. Global Artificial Heart Lung Machines Sales Market Share by Region (2021-2026) Table 46. Global Artificial Heart Lung Machines Sales by Region (2027-2032) & (Units) Table 47. Global Artificial Heart Lung Machines Sales Market Share by Region (2027-2032) Table 48. Global Artificial Heart Lung Machines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Artificial Heart Lung Machines Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Artificial Heart Lung Machines Sales Value Share by Region (2021-2026) Table 51. Global Artificial Heart Lung Machines Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Artificial Heart Lung Machines Sales Value Share by Region (2027-2032) Table 53. Global Artificial Heart Lung Machines Market Average Price (K USD/Unit) by Region (2021-2026) Table 54. Global Artificial Heart Lung Machines Market Average Price (K USD/Unit) by Region (2027-2032) Table 55. Global Artificial Heart Lung Machines Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Artificial Heart Lung Machines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 58. Global Artificial Heart Lung Machines Sales Market Share by Country (2021-2026) Table 59. Global Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 60. Global Artificial Heart Lung Machines Sales Market Share by Country (2027-2032) Table 61. Global Artificial Heart Lung Machines Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Artificial Heart Lung Machines Sales Value Market Share by Country (2021-2026) Table 63. Global Artificial Heart Lung Machines Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Artificial Heart Lung Machines Sales Value Market Share by Country (2027-2032) Table 65. LivaNova (Sorin) Company Information Table 66. LivaNova (Sorin) Business Overview Table 67. LivaNova (Sorin) Artificial Heart Lung Machines Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 68. LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio Table 69. LivaNova (Sorin) Recent Development Table 70. Getinge (Maquet) Company Information Table 71. Getinge (Maquet) Business Overview Table 72. Getinge (Maquet) Artificial Heart Lung Machines Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 73. Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio Table 74. Getinge (Maquet) Recent Development Table 75. Medtronic Company Information Table 76. Medtronic Business Overview Table 77. Medtronic Artificial Heart Lung Machines Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 78. Medtronic Artificial Heart Lung Machines Product Portfolio Table 79. Medtronic Recent Development Table 80. Terumo CV Group Company Information Table 81. Terumo CV Group Business Overview Table 82. Terumo CV Group Artificial Heart Lung Machines Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 83. Terumo CV Group Artificial Heart Lung Machines Product Portfolio Table 84. Terumo CV Group Recent Development Table 85. Braile Biomedica Company Information Table 86. Braile Biomedica Business Overview Table 87. Braile Biomedica Artificial Heart Lung Machines Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 88. Braile Biomedica Artificial Heart Lung Machines Product Portfolio Table 89. Braile Biomedica Recent Development Table 90. Tianjin Medical Company Information Table 91. Tianjin Medical Business Overview Table 92. Tianjin Medical Artificial Heart Lung Machines Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 93. Tianjin Medical Artificial Heart Lung Machines Product Portfolio Table 94. Tianjin Medical Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Artificial Heart Lung Machines Distributors List Table 98. Artificial Heart Lung Machines Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Artificial Heart Lung Machines Product Image Figure 2. Global Artificial Heart Lung Machines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Heart Lung Machines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Artificial Heart Lung Machines Sales (2021-2032) & (Units) Figure 5. Global Artificial Heart Lung Machines Sales Average Price (K USD/Unit) & (2021-2032) Figure 6. Global Artificial Heart Lung Machines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Roller Pump HLM Image Figure 10. Double Roller Pump HLM Image Figure 11. Global Artificial Heart Lung Machines Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Artificial Heart Lung Machines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Artificial Heart Lung Machines Sales Volume Share by Type (2021-2032) Figure 14. Global Artificial Heart Lung Machines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Artificial Heart Lung Machines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Artificial Heart Lung Machines Sales Value Share by Type (2021-2032) Figure 17. Cardiac Surgery Image Figure 18. Lung Transplant Operation Image Figure 19. Acute Respiratory Failure Treatment Image Figure 20. Others Image Figure 21. Global Artificial Heart Lung Machines Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Artificial Heart Lung Machines Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Artificial Heart Lung Machines Sales Volume Share by Application (2021-2032) Figure 24. Global Artificial Heart Lung Machines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Artificial Heart Lung Machines Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Artificial Heart Lung Machines Sales Value Share by Application (2021-2032) Figure 27. Global Artificial Heart Lung Machines Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Artificial Heart Lung Machines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Artificial Heart Lung Machines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Artificial Heart Lung Machines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Artificial Heart Lung Machines Sales Value (2021-2032) & (US$ Million) Figure 32. North America Artificial Heart Lung Machines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Artificial Heart Lung Machines Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Artificial Heart Lung Machines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Artificial Heart Lung Machines Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Artificial Heart Lung Machines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Artificial Heart Lung Machines Sales Value (2021-2032) & (US$ Million) Figure 38. South America Artificial Heart Lung Machines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Artificial Heart Lung Machines Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Artificial Heart Lung Machines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Artificial Heart Lung Machines Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Artificial Heart Lung Machines Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Single Roller Pump HLM
  • Double Roller Pump HLM
Applications
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Others
Companies covered
  • LivaNova (Sorin)
  • Getinge (Maquet)
  • Medtronic
  • Terumo CV Group
  • Braile Biomedica
  • Tianjin Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artificial Heart Lung Machines Sales Value (2021-2032)
  4. 1.2.2 Global Artificial Heart Lung Machines Sales Volume (2021-2032)
  5. 1.2.3 Global Artificial Heart Lung Machines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Artificial Heart Lung Machines Market Dynamics
  1. 2.1 Artificial Heart Lung Machines Industry Trends
  2. 2.2 Artificial Heart Lung Machines Industry Drivers
  3. 2.3 Artificial Heart Lung Machines Industry Opportunities and Challenges
  4. 2.4 Artificial Heart Lung Machines Industry Restraints
3 Artificial Heart Lung Machines Market by Company
  1. 3.1 Global Artificial Heart Lung Machines Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Heart Lung Machines Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Heart Lung Machines Sales Volume by Company (2021-2026)
  4. 3.4 Global Artificial Heart Lung Machines Average Price by Company (2021-2026)
  5. 3.5 Global Artificial Heart Lung Machines Company Ranking (2024-2026)
  6. 3.6 Global Artificial Heart Lung Machines Company Manufacturing Base and Headquarters
  7. 3.7 Global Artificial Heart Lung Machines Company Product Type and Application
  8. 3.8 Global Artificial Heart Lung Machines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Artificial Heart Lung Machines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Artificial Heart Lung Machines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Artificial Heart Lung Machines Market by Type
  1. 4.1 Artificial Heart Lung Machines Type Introduction
  2. 4.1.1 Single Roller Pump HLM
  3. 4.1.2 Double Roller Pump HLM
  4. 4.2 Global Artificial Heart Lung Machines Sales Volume by Type
  5. 4.2.1 Global Artificial Heart Lung Machines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artificial Heart Lung Machines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Artificial Heart Lung Machines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Artificial Heart Lung Machines Sales Value by Type
  9. 4.3.1 Global Artificial Heart Lung Machines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Artificial Heart Lung Machines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Artificial Heart Lung Machines Sales Value Share by Type (2021-2032)
5 Artificial Heart Lung Machines Market by Application
  1. 5.1 Artificial Heart Lung Machines Application Introduction
  2. 5.1.1 Cardiac Surgery
  3. 5.1.2 Lung Transplant Operation
  4. 5.1.3 Acute Respiratory Failure Treatment
  5. 5.1.4 Others
  6. 5.2 Global Artificial Heart Lung Machines Sales Volume by Application
  7. 5.2.1 Global Artificial Heart Lung Machines Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Artificial Heart Lung Machines Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Artificial Heart Lung Machines Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Artificial Heart Lung Machines Sales Value by Application
  11. 5.3.1 Global Artificial Heart Lung Machines Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Artificial Heart Lung Machines Sales Value by Application (2021-2032)
  13. 5.3.3 Global Artificial Heart Lung Machines Sales Value Share by Application (2021-2032)
6 Artificial Heart Lung Machines Regional Sales and Value Analysis
  1. 6.1 Global Artificial Heart Lung Machines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Heart Lung Machines Sales by Region (2021-2032)
  3. 6.2.1 Global Artificial Heart Lung Machines Sales by Region: 2021-2026
  4. 6.2.2 Global Artificial Heart Lung Machines Sales by Region (2027-2032)
  5. 6.3 Global Artificial Heart Lung Machines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Artificial Heart Lung Machines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Artificial Heart Lung Machines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Artificial Heart Lung Machines Sales Value by Region (2027-2032)
  9. 6.5 Global Artificial Heart Lung Machines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Artificial Heart Lung Machines Sales Value (2021-2032)
  12. 6.6.2 North America Artificial Heart Lung Machines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Artificial Heart Lung Machines Sales Value (2021-2032)
  15. 6.7.2 Europe Artificial Heart Lung Machines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Artificial Heart Lung Machines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Artificial Heart Lung Machines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Artificial Heart Lung Machines Sales Value (2021-2032)
  21. 6.9.2 South America Artificial Heart Lung Machines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Artificial Heart Lung Machines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Artificial Heart Lung Machines Sales Value Share by Country, 2025 VS 2032
7 Artificial Heart Lung Machines Country-level Sales and Value Analysis
  1. 7.1 Global Artificial Heart Lung Machines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Heart Lung Machines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Artificial Heart Lung Machines Sales by Country (2021-2032)
  4. 7.3.1 Global Artificial Heart Lung Machines Sales by Country (2021-2026)
  5. 7.3.2 Global Artificial Heart Lung Machines Sales by Country (2027-2032)
  6. 7.4 Global Artificial Heart Lung Machines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Artificial Heart Lung Machines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Artificial Heart Lung Machines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Artificial Heart Lung Machines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Artificial Heart Lung Machines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Artificial Heart Lung Machines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 LivaNova (Sorin)
  2. 8.1.1 LivaNova (Sorin) Company Information
  3. 8.1.2 LivaNova (Sorin) Business Overview
  4. 8.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio
  6. 8.1.5 LivaNova (Sorin) Recent Developments
  7. 8.2 Getinge (Maquet)
  8. 8.2.1 Getinge (Maquet) Company Information
  9. 8.2.2 Getinge (Maquet) Business Overview
  10. 8.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio
  12. 8.2.5 Getinge (Maquet) Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Artificial Heart Lung Machines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Artificial Heart Lung Machines Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Terumo CV Group
  20. 8.4.1 Terumo CV Group Company Information
  21. 8.4.2 Terumo CV Group Business Overview
  22. 8.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Terumo CV Group Artificial Heart Lung Machines Product Portfolio
  24. 8.4.5 Terumo CV Group Recent Developments
  25. 8.5 Braile Biomedica
  26. 8.5.1 Braile Biomedica Company Information
  27. 8.5.2 Braile Biomedica Business Overview
  28. 8.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Braile Biomedica Artificial Heart Lung Machines Product Portfolio
  30. 8.5.5 Braile Biomedica Recent Developments
  31. 8.6 Tianjin Medical
  32. 8.6.1 Tianjin Medical Company Information
  33. 8.6.2 Tianjin Medical Business Overview
  34. 8.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tianjin Medical Artificial Heart Lung Machines Product Portfolio
  36. 8.6.5 Tianjin Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artificial Heart Lung Machines Value Chain Analysis
  2. 9.1.1 Artificial Heart Lung Machines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artificial Heart Lung Machines Sales Mode & Process
  6. 9.2 Artificial Heart Lung Machines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artificial Heart Lung Machines Distributors
  9. 9.2.3 Artificial Heart Lung Machines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst